Navigation Links
New Drug Could Reduce Stroke Complications

Glasgow University researchers have said that a new drug holds considerable promise in cutting down the complications that arise after a stroke. The reserachers arrived at this conclusion after testing this drug// on 1,700 patients in 154 hospitals across the world.

The treatment, called NXY-059, reduces the amount of brain damage that occurs just after the patient has suffered a clot-related stroke, which is caused by a blockage in the blood vessels that supply the brain. Complications of such a stroke include facial weakness, arm weakness and speech problems. In the current study, patients who were admitted into the hospital within six hours of developing a stroke were examines and 50 percent of them received normal fluids, while the others received fluids as well as NXY-059. Patients who were given this new drug were more likely to have made a full recovery from stroke after three months, said lead researcher Professor Kennedy Lees. Their odds of avoiding disability were about 20% better if they were given NXY-059. This trial opens up new horizons for treatment of one of the most important conditions affecting our society. He added that the availability of the drug meant that patients could be given treatment three hours after the symptoms of a stroke developed. The reserachers also said that this drug could also reduce the bleeding associated with clot dissolving drugs. Stroke is one of the leading causes of death and disability worldwide and this treatment has opened up new avenues in the treatment of the condition. Commenting on the new study, David Clark, chief executive of the charity Chest said, About half of all stroke survivors have some significant disability, so anything which reduces this disability is potentially of great benefit, especially as this has the potential to be developed as a routine treatment in all stroke units.


Page: 1

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Nasal Spray Could Take Drugs Direct to Brain.
3. Nasal Spray Could Take Drugs Directly to Brain
4. Oxygen Usage During Exercise Could Indicate Heart Problems
5. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
6. Anger Could Be Linked To Weight Gain
7. A Seizure Late In Life Could be A Stroke Warning
8. New Findings Could Reduce The Extent Of Spinal Cord Injuries
9. Could There Be A Link Between Famine and Breast Cancer ?
10. Bone Marrow Cells Could Yield A New Lease of Life
11. New Hair in 15 Days Could Now Be A Possibility Say Researchers
Post Your Comments:

(Date:11/30/2015)... ... November 30, 2015 , ... An ... directory is specialized and only includes chiropractic clinics in the US. , The ... trustworthy alternative health practitioner when back pain sets in. When people are experiencing ...
(Date:11/30/2015)... ... November 30, 2015 , ... In ... Halloween festivities, the Word of Life Christian Church of Flint, MI, hosted a ... a giant 1.25 ton pile of candy dubbed “Candy Mountain”. , A Forever ...
(Date:11/30/2015)... ... November 30, 2015 , ... During ... fundraising campaign to raise funds for its research, education, support, and advocacy efforts. ... organization’s annual funding. , The Mesothelioma Applied Research Foundation, which also goes by ...
(Date:11/30/2015)... ... November 30, 2015 , ... The ... in Dallas, TX, on January 29 and 30, 2016. The course welcomes dental ... of their practices, to learn how to better succeed in the modern dental ...
(Date:11/30/2015)... ... November 30, 2015 , ... HemoTreat™ has announced that the ... ointment to its website. , “Our goal is simple:” says Michael Blasco, HemoTreat’s ... the comparison chart and ingredient list allows our customers to quickly see why, ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... Free Press as a Top Workplace , among the ... work for in 2015. ... annually, based on employee surveys rating company leadership, career opportunities, ... based solely on employee feedback. The survey is conducted by ...
(Date:11/30/2015)...  IBA Molecular North America, Inc. (IBAMNA), a U.S. ... that as of January 1, 2016, it will do ... to rebrand the company reflects a refined vision for ... close relationship with Zevacor Molecular.  Both IBAMNA and Zevacor ... Peter Burke , Vice President Sales ...
(Date:11/30/2015)... 30, 2015 Baxalta Incorporated (NYSE: ... dedicated to delivering transformative therapies to patients ... today announced the launch and first shipments ... extended circulating half-life recombinant factor VIII (rFVIII) ... ADVATE [Antihemophilic Factor (Recombinant)]. The treatment was ...
Breaking Medicine Technology: